TXG Logo

10x Genomics, Inc. (TXG) 

NASDAQ$10.76+0.42 (4.06%)
Market Cap
$1.26B
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
189 of 924
Rank in Industry
7 of 40

TXG Insider Trading Activity

TXG Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$445,57218
Sells
$968,4431192

Related Transactions

MATEO ALANdirector1$445,5720$0$445,572
McAnear Justin J.Chief Financial Officer0$02$138,066$-138,066
Hindson Benjamin J.See Remarks0$04$327,444$-327,444
Saxonov SergeChief Executive Officer0$05$502,933$-502,933

About 10x Genomics, Inc.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for â€¦

Insider Activity of 10x Genomics, Inc.

Over the last 12 months, insiders at 10x Genomics, Inc. have bought $445,572 and sold $968,443 worth of 10x Genomics, Inc. stock.

On average, over the past 5 years, insiders at 10x Genomics, Inc. have bought $229,183 and sold $281.78M worth of stock each year.

Highest buying activity among insiders over the last 12 months: MATEO ALAN (director) — $445,572.

The last purchase of 40,000 shares for transaction amount of $445,572 was made by MATEO ALAN (director) on 2025‑02‑21.

List of Insider Buy and Sell Transactions, 10x Genomics, Inc.

2025-02-28SaleSaxonov SergeChief Executive Officer
7,942
0.0065%
$10.63$84,393+0.09%
2025-02-24SaleSaxonov SergeChief Executive Officer
5,092
0.0042%
$11.07$56,346-4.38%
2025-02-24SaleHindson Benjamin J.See Remarks
4,573
0.0038%
$11.07$50,603-4.38%
2025-02-21PurchaseMATEO ALANdirector
40,000
0.0315%
$11.14$445,572-5.88%
2024-11-22SaleSaxonov SergeChief Executive Officer
6,693
0.0052%
$13.69$91,612+2.52%
2024-11-22SaleHindson Benjamin J.See Remarks
5,807
0.0045%
$13.69$79,485+2.52%
2024-08-22SaleSaxonov SergeChief Executive Officer
6,749
0.0057%
$22.53$152,053-30.61%
2024-08-22SaleHindson Benjamin J.See Remarks
4,351
0.0037%
$22.53$98,027-30.61%
2024-08-22SaleMcAnear Justin J.Former Chief Financial Officer
2,961
0.0025%
$22.53$66,710-30.61%
2024-05-22SaleSaxonov SergeChief Executive Officer
4,877
0.0041%
$24.30$118,529-32.20%
2024-05-22SaleHindson Benjamin J.See Remarks
4,087
0.0034%
$24.30$99,329-32.20%
2024-05-22SaleMcAnear Justin J.Chief Financial Officer
2,936
0.0025%
$24.30$71,355-32.20%
2024-03-04SaleSaxonov SergeChief Executive Officer
4,660
0.0038%
$44.00$205,021-56.02%
2024-02-22SaleSaxonov SergeChief Executive Officer
2,821
0.0028%
$46.34$130,737-56.32%
2024-02-22SaleHindson Benjamin J.See Remarks
2,613
0.0026%
$46.34$121,098-56.32%
2024-02-22SaleMcAnear Justin J.Chief Financial Officer
1,865
0.0018%
$46.34$86,432-56.32%
2024-02-15SaleSaxonov SergeChief Executive Officer
5,000
0.0043%
$48.87$244,332-58.37%
2024-02-09SaleSaxonov SergeChief Executive Officer
1,000
0.001%
$49.53$49,530-59.12%
2024-01-16SaleSaxonov SergeChief Executive Officer
4,000
0.0034%
$45.24$180,956-51.06%
2023-12-14SaleSaxonov SergeChief Executive Officer
2,000
0.0017%
$55.03$110,065-59.07%
Total: 235
*Gray background shows transactions not older than one year

Insider Historical Profitability

16.57%
McAnear Justin J.Former Chief Financial Officer
143242
0.1171%
$1.48M138<0.0001%
MATEO ALANdirector
61691
0.0504%
$637,884.9410
Foresite Capital Management I, LLC10 percent owner
2350000
1.9215%
$24.3M12+46.56%
ROBERTS BRYAN Edirector
1287825
1.053%
$13.32M11+41.14%
CRUTCHFIELD BRADFORDChief Commercial Officer
97237
0.0795%
$1.01M131<0.0001%
*Gray background shows insiders who have made transactions during last year

TXG Institutional Investors: Active Positions

Increased Positions153+47.66%19M+17.34%
Decreased Positions144-44.86%17M-15.71%
New Positions63New12MNew
Sold Out Positions52Sold Out7MSold Out
Total Postitions330+2.8%109M+1.63%

TXG Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Fmr Llc$139,119.0012.46%13.45M+86,455+0.65%2024-12-31
Ark Investment Management Llc$123,502.0011.06%11.94M+1M+11.1%2024-12-31
Vanguard Group Inc$113,053.0010.12%10.93M-39,381-0.36%2024-12-31
Blackrock, Inc.$70,004.006.27%6.77M-45,119-0.66%2024-12-31
Sumitomo Mitsui Trust Group, Inc.$59,077.005.29%5.71M-659,728-10.35%2024-12-31
Nikko Asset Management Americas, Inc.$59,077.005.29%5.71M-659,728-10.35%2024-12-31
Morgan Stanley$40,587.003.64%3.93M-3M-39.39%2024-12-31
Ra Capital Management, L.P.$33,909.003.04%3.28M+3MNew2024-12-31
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Ame$21,885.001.96%2.12M+193,588+10.07%2024-12-31
Venrock Management Vi, Llc$21,784.001.95%2.11M00%2024-09-30

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
2.59SellsBuysStrong BuyBuyHoldSellStrong SellTXGHighAverageLowSeries 4